Clinical Practice Guidelines by Tumour Type
The ESMO Clinical Practice Guidelines (CPG) are intended to provide oncology professionals with a set of recommendations for the best standards of cancer care, based on the findings of evidence-based medicine.
Produced under the direction of the ESMO Guidelines Committee, each Clinical Practice Guideline includes information on the incidence of the malignancy, diagnostic criteria, staging of disease and risk assessment, treatment plans and follow-up designed to help oncologists deliver an appropriate quality of care to their patients.
New for 2015: Thymic Epithelial Tumours, Hairy Cell Leukaemia, Philadelphia Chromosome-Negative Chronic Myeloproliferative Neoplasms, Central Venous Access in Oncology, and Treatment of Dyspnoea in Advanced Cancer Patients.
Plus, the 2015 updates of the Primary Breast Cancer, Cancers of Unknown Primary Site, Cancer of the Pancreas, Diffuse Large B-Cell Lymphoma, Chronic Lymphocytic Leukaemia, Peripheral T-Cell Lymphomas, Cutaneous Melanoma, Management of Oral and Gastrointestinal Mucosal Injury, Prostate Cancer and Malignant Pleural Mesothelioma guidelines are also now online.